|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| Operating Expenses | |||||
| Total operating expenses | |||||
| Other income/(expense): | |||||
| Finance income | |||||
| Finance expense | |||||
| Finance expense (net) | |||||
| Loss from operations before income taxes | |||||
| Income tax | |||||
| Loss for the year | |||||
| Other Comprehensive loss: | |||||
| Exchange differences on translating foreign operations | |||||
| Comprehensive loss | |||||
| Basic loss per share attributable to common shareholders | |||||
| Diluted loss per share attributable to common shareholders | |||||
Loading...